Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies

QR Code

Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies

The presence and severity of cognitive symptoms, including working memory, executive dysfunction and attentional impairment, contributes materially to functional impairment in schizophrenia. Cognitive symptoms have proven resistant to both first- and second-generation antipsychotic drugs. Efforts to...

Full description

Bibliographic Details
Main Authors:	O'Tuathaigh, C.M.P., Moran, P.M., Zhen, X.C., Waddington, J.L.
Format:	Article
Published:	Wiley 2017
Online Access:	https://eprints.nottingham.ac.uk/43662/

Similar Items

Gene × environment interactions in schizophrenia: evidence from genetic mouse models
by: Moran, Paula M., et al.
Published: (2016)

D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors
by: Bay-Richter, C., et al.
Published: (2013)

The Cellular and Molecular Basis of Translational Immunometabolism
by: Norata, Giuseppe, et al.
Published: (2015)

Specialised information processing deficits and distinct metabolomics profiles following TM-domain disruption of Nrg1
by: O'Tuathaigh, C.M.P., et al.
Published: (2017)

Cognitive insight and verbal learning in schizophrenia
by: Lua, Chong Teck
Published: (2015)

The cognitive profiling of the methylazoxymethanol acetate model of schizophrenia
by: Malik, Nadia
Published: (2013)

A controlled study of cognitive psychotherapy in schizophrenia
by: Zain, Azhar
Published: (2002)

The molecular basis of peroxisome proliferation
by: Bell, Alexander
Published: (1998)

Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2) deficient mice: Do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?
by: O'Callaghan, M.J., et al.
Published: (2014)

Insight in Offenders with Schizophrenia: Relationship to Psychopathology and Cognitive Function
by: Othman, Zahiruddin, et al.
Published: (2017)

Tualang honey supplementation as cognitive enhancer in patients with schizophrenia
by: Yahaya, Rosliza, et al.
Published: (2020)

Speech act as basis for dialoguecoherence : a case of English–Yoruba translation
by: Yekeen, Bello, et al.
Published: (2021)

Contributing factors to cognitive deficits in psychometric schizotypy: implications for schizophrenia
by: Dawes, Christopher
Published: (2023)

Cognitive deficits among supported employment clients with schizophrenia / Normala Sorikan
by: Normala, Sorikan
Published: (2019)

Cognitive Insight in Schizophrenia: Its Relationship with Verbal Learning and Clinical Insight
by: Othman, Zahiruddin, et al.
Published: (2018)

The molecular basis of atypicality in antipsychotic drug action
by: Lockington, Hannah J.
Published: (2025)

Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia.
by: McCarthy, N., et al.
Published: (2017)

Keloid Scarring: Understanding the Genetic Basis, Advances, and Prospects
by: Halim, Ahmad Sukari, et al.
Published: (2012)

Cognitive remediation has global cognitive and functional benefits for people with schizophrenia when combined with psychiatric rehabilitation
by: Cordier, Reinie, et al.
Published: (2012)

The Influence of Neurexin 1 Gene Variants on Cognitive Ability in Multiplex Schizophrenia Families
by: Wang, Kah Wei
Published: (2017)

Managing ‘Schizophrenia in the Midst of Schizophrenia’- the role of assertive community treatment.
by: Ahmad Nabil MR,, et al.
Published: (2014)

Managing ‘schizophrenia in the midst of schizophrenia’- the role of assertive community treatment
by: Md Rosli, Ahmad Nabil, et al.
Published: (2014)

Molecular Basis of CYP2B2 Induction
by: Horley, Neill
Published: (1999)

The molecular and phenotypic basis of the glioma invasive perivascular niche
by: Diksin, Mohammed, et al.
Published: (2017)

Investigating the molecular basis of biased signalling at cannabinoid receptors
by: Dennis, Morgan Jane
Published: (2023)

Molecular basis of primary and secondary resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)

Molecular basis of alpha thalassemia among aborigines in Kelantan
by: Rusli, Nurul Atikah
Published: (2016)

Neural primacy of the salience processing system in schizophrenia
by: Palaniyappan, Lena, et al.
Published: (2013)

The molecular basis of Gs protein efficacy at the b2- adrenoceptor
by: Harwood, Clare
Published: (2022)

Discovering the molecular basis for ligand pharmacological activity on β-adrenoceptors
by: Bunsuz, Asuman
Published: (2023)

Neurotransmitter profiling with high and ultra-high field magnetic resonance spectroscopy : optimization for clinical and translational studies in schizophrenia
by: Napolitano, Antonio
Published: (2011)

Probability and magnitude evaluation in schizophrenia
by: Albrecht, Matthew, et al.
Published: (2016)

Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah
by: Teh, Lai Kuan, et al.
Published: (2014)

Disrupted-in-schizophrenia-1 SNPs and susceptibility to schizophrenia: evidence from Malaysia
by: A. Talib, Norlelawati, et al.
Published: (2015)

Gallstone, snake venom and witchcraft for schizophrenia: the challenges of classifying [schizophrenia] trials
by: Shokraneh, Farhad, et al.
Published: (2018)

Carotenoid as a potential antioxidant marker for schizophrenia
by: Chow, T.J, et al.
Published: (2012)

The role of dopamine D2 and neuregulin-1 receptors in schizophrenia relevant phenotypes of cognition, attention and memory
by: Mathur, Naina
Published: (2012)

Clozapine dose for schizophrenia
by: Subramanian, Selvizhi, et al.
Published: (2017)

Reviewing the epigenetics of schizophrenia
by: Cromby, John, et al.
Published: (2016)

Trichotillomania Comorbid with Schizophrenia
by: Othman, Zahiruddin, et al.
Published: (2019)